The abnormal growth of vascular smooth muscle cells (VSMCs) is considered a critical pathogenic process in inflammatory vascular diseases. We have previously demonstrated that protein phosphatase 2 A (PP2A)-mediated NF-kB dephosphorylation contributes to the anti-inflammatory properties of andrographolide, a novel NF-kB inhibitor. In this study, we investigated whether andrographolide causes apoptosis, and characterized its apoptotic mechanisms in rat VSMCs. Andrographolide activated the p38 mitogen-activated protein kinase (p38MAPK), leading to p53 phosphorylation. Phosphorylated p53 subsequently transactivated the expression of Bax, a pro-apoptotic protein. Transfection with pp2a small interfering RNA (siRNA) suppressed andrographolide-induced p38MAPK activation, p53 phosphorylation, and caspase 3 activation. Andrographolide also activated the Src homology 1 domain-containing protein tyrosine phosphatase (SHP-1), and induced PP2A dephosphorylation, both of which were inhibited by the SHP-1 inhibitor sodium stibogluconate (SSG) or shp-1 siRNA. SSG or shp-1 siRNA prevented andrographolide-induced apoptosis. These results suggest that andrographolide activates the PP2A-p38MAPK-p53-Bax cascade, causing mitochondrial dysfunction and VSMC death through an SHP-1-dependent mechanism.
Reversible protein phosphorylation catalyzed by protein kinases and protein phosphatases regulates various cellular processes, including inflammation and apoptosis 17, 18 . Recent studies have highlighted a major role of serine/threonine protein phosphatases, including that of PP2A in apoptosis 19, 20 . The PP2A is a member of the ceramide-activated protein phosphatases (CAPPs) that is composed of regulatory subunits A and B and a catalytic subunit C 21 . The activity of PP2A is regulated by interactions of regulatory subunits 22 or by post-translational modifications, including methylation 23 and phosphorylation 21, 24 . The methylation of PP2A at Leu-309 activates PP2A 23 , and phosphorylation at Tyr-307 suppresses PP2A catalytic activity 21 .
The role of PP2A in cell apoptosis has been shown to involve the upregulation of Bim 20 or Bax 19 , which are both pro-apoptotic members of the Bcl-2 family. The Bcl-2 family includes proteins with antiapoptotic or pro-apoptotic properties that regulate the intrinsic (mitochondrial) apoptotic pathway 25 . Both Bim and Bax independently interfere with the anti-apoptotic functions of other Bcl-2 family members 26 . The tumor suppressor protein p53 is a transcription factor that has been shown to induce apoptosis by causing mitochondrial dysfunction through the transactivation of Bax expression 19, 27 . The p53 protein is activated primarily by phosphorylation of Ser-15 28 .
We have previously shown that the p38 mitogen-activated protein kinase (MAPK) mediates the phosphorylation of Ser-15 in p53 and the subsequent expression of Bax during apoptosis in cerebral endothelial cells 21, 29 . Because pro-apoptotic Bcl-2 family members, such as Bax, are believed to contribute to the apoptotic actions of andrographolide 12, 13 , we investigated whether p53 contributes to andrographolide-induced apoptosis in VSMCs. Our findings support the contention that the activation of a PP2A-p38MAPK-p53-Bax pathway mediated by the Src homology 1 domain-containing protein tyrosine phosphatase (SHP-1) contributes to andrographolide-induced apoptosis in VSMCs.
Results
Andrographolide induced cell apoptosis in rat VSMCs. An MTT assay was used to examine the effects of andrographolide on cell viability in rat VSMCs. As shown in Figure 1a , treatment with 50 mM andrographolide significantly decreased cell viability by 20.8% 6 4.3% and 75.8% 6 5.2% after 24 h and 48 h, respectively (n 5 4). Treatment with 20 or 50 mM andrographolide induced changes in cellular morphology, with cells becoming round and shrunken ( Figure 1b ). We also determined whether andrographolide induced VSMC death by apoptosis. In healthy cells, the phosphatidylserine (PS) groups in the plasma membrane are directed toward the inside of the cell. However, the PS groups are exposed to the environment upon apoptosis. We used supravital exposure to propidium iodide and annexin V double labeling for the detection of apoptosis. Compared with the vehicle-treated cells (control group, Figure 1c , panel i), the cells treated with 20 mM (Figure 1c , panel ii) or 50 mM (Figure 1c , panel iii) andrographolide showed a higher proportion of annexin V labeling, compared with control cells, and displayed 2 levels of labeling. The annexin V 1 PI 2 cells (lower right quadrant) represented early apoptotic cells, and the annexin V 1 PI 1 cells (upper right quadrant) represented advanced apoptotic cells and/or necrotic cells. These results suggest that andrographolide induced apoptosis in the rat aortic VSMCs.
Andrographolide activated mitochondrial apoptotic pathway in rat VSMCs. Mitochondria are thought to be the major pathway for apoptosis 30, 31 . The pro-apoptotic Bcl-2 family member Bax plays a crucial role in the mitochondrial control of apoptosis 32 . To determine whether the mitochondrial apoptotic signaling pathway was involved in the andrographolide-induced apoptosis of rat aortic VSMCs, the expression profile of Bax was examined. As shown in Figure 2a , treatment with 20 or 50 mM andrographolide for 48 h significantly induced Bax expression by 1.6 6 0.1 fold and 2.4 6 0.1 fold, respectively (n 5 3).
The change of mitochondria membrane potential (Dym) is an important factor in inducing apoptosis 32 . We used the selective mitochondrial uptake of the JC-1 dye to examine the Dym following treatment with andrographolide. When the mitochondrial membrane potential decreases, the JC-1 dye selectively enters the mitochondria matrix, and the color of JC-1 fluorescence changes from red to green. The healthy living cells maintain a high mitochondrial membrane potential, and JC-1 spontaneously forms the red Jaggregates, whereas apoptotic cells have a low potential, resulting in the formation of the green JC-1 monomers. As shown in Figure 2b , treatment with 20 or 50 mM andrographolide induced a negative Dym in rat VSMCs, compared with the vehicle-treated control group.
Because an increase in the permeability of the outer mitochondria membrane leads to the release of several apoptotic factors, such as cytochrome c, that activate caspases which mediate apoptosis, we examined the activation of caspase-9 and caspase-3 in andrographolide-treated VSMCs. As shown in Figure 2c , the level of the cleaved, activated form of caspase-9 increased following treatment with andrographolide for 48 h (n 5 4). The andrographolide treatment also caused an increase in the level of the cleaved, activated form of caspase-3 (n 5 4) ( Figure 2d ) These observations indicate that andrographolide induces mitochondrial apoptosis in rat VSMCs.
Andrographolide-induced p53 phosphorylation and activation in rat VSMCs is mediated by p38MAPK. The transcription factor p53 has been shown to induce apoptosis by causing mitochondrial dysfunction through the transactivation of Bax 33, 34 . The phosphorylation of p53 at Ser-15 has been shown to contribute to its activation 28 . To explore the role of p53 in andrographolide-induced VSMC apoptosis, we examined the effect of andrographolide on the phosphorylation of Ser-15 in p53. As shown in Figure 3a , treatment with andrographolide increased p53 Ser-15 phosphorylation. Following andrographolide treatment, detectable phosphorylation began at 10 min, peaked at 20 min, and declined to basal levels after 30 min (n 5 4).
We have previously demonstrated that p38MAPK signaling is responsible for p53 Ser-15 phosphorylation in cerebral endothelial cells 19 and colon cancer cells 35 . Thus, we examined whether p38MAPK phosphorylation is altered in rat VSMCs treated with andrographolide. As shown in Figure 3b , treatment with andrographolide induced p38MAPK phosphorylation (n 5 3). We also examined whether p38MAPK contributes to andrographolide-induced VSMC death using the p38MAPK signaling inhibitors, SB203580 and p38MAPK inhibitor III. Pretreatment with SB203580 (10 mM) or p38MAPK inhibitor III (1 mM) significantly restored andrographolide-decreased cell viability (n 5 4) ( Figure 3c ).
We also used a PGl3-Luc reporter construct that contained a p53 DNA-binding site linked to a basal promoter that controls the expression of a luciferase reporter gene 36 to examine whether p53 transactivation increases in cells exposed to andrographolide. As shown in Figure 3d , cells treated with 50 mM andrographolide for 24 h exhibited an increase in PG13-luciferase activity of 3.5 6 0.5 fold (n 5 5). The pretreatment of cells with SB203580 inhibited the andrographolide-induced increase in PG13-luciferase activity (Figure 3d ), and suppressed Bax expression ( Figure 3e ) in rat VSMCs exposed to andrographolide. These results suggest that p38MAPK may mediate p53 activation, Bax expression, and apoptosis in rat VSMCs treated with andrographolide.
PP2A mediates andrographolide-activated p38MAPK-p53 cascade in rat VSMCs. We investigated the signaling molecules that may contribute to the andrographolide-induced activation of the p38MAPK-p53-Bax cascade in rat VSMCs. We recently demonstrated www.nature.com/scientificreports SCIENTIFIC REPORTS | 4 : 5651 | DOI: 10.1038/srep05651 that andrographolide increased the protein phosphatase activity of PP2A in rat VSMCs 16 . In addition, PP2A activates p53 19 , and PP2A has been shown to contribute to various cellular responses through the regulation of ASK1, p38MAPK, and JNK 18, 19 . We examined the effects of pp2a siRNA in rat VSMCs exposed to andrographolide to determine the relationship between PP2A activation and the p38MAPK-p53 cascade. Transfection of rat VSMCs with pp2a siRNA significantly inhibited andrographolide-increased p38 MAPK ( Figure 4a ) and p53 (Figure 4b ) phosphorylation. The pp2a siRNA also reduced the andrographolide-induced activation of caspase-3 ( Figure 4c ). Furthermore, pp2a siRNA significantly restored andrographolide-decreased cell viability in rat VSMCs . siRNA experiments also revealed that pp2a siRNA suppressed the basal level of PP2A-C ( Figure 4e ). These results suggest that PP2A may be responsible for the andrographolideinduced activation of the p38MAPK-p53 cascade in rat VSMCs.
Andrographolide activated SHP-1 in rat VSMCs. The precise mechanism involved in the andrographolide-induced activation of PP2A in rat VSMCs remains unclear. We previously demonstrated that PP2A is activated by the neutrosphingomyelinase-ceramide cascade in rat VSMCs exposed to andrographolide 16 . However, PP2A activity may also be regulated by methylation or phosphorylation 21, 23, 24 . Thus, we examined whether the methylation or phosphorylation of PP2A-C is altered by andrographolide. As shown in Figure 5a , treatment with andrographolide had no effect on the level of demethylated PP2A-C (DM-PP2A-C, inactive form). However, treatment with andrographolide for 10 to 30 min caused a significant decrease in the phosphorylation of Tyr-307 in PP2A (Figure 5a ), whereas the total level of PP2A-C was not changed. These results indicate that andrographolide may activate PP2A by regulating PP2A-C Tyr-307 phosphorylation.
We investigated the underlying mechanism by which andrographolide induces PP2A Tyr-307 dephosphorylation. Andrographolide may activate a protein tyrosine phosphatase that dephosphorylates PP2A-C Tyr-307, leading to PP2A activation. Activation of SHP-1 was recently shown to play an important role in the vascular protective effects of estrogen in rat VSMCs 37 . We, therefore, explored whether SHP-1 is involved in PP2A-C dephosphorylation. Pretreatment with the selective SHP-1 inhibitor SSG 38 reduced PP2A-C Tyr-307 dephosphorylation in rat VSMCs treated with andrographolide ( Figure 5b ). Pretreatment with SSG also inhibited the andrographolide-induced reduction in cell viability in rat VSMCs (Figure 5c ). To further confirm more specifically that andrographolide-induced PP2A-C Tyr-307 dephosphorylation was mediated by SHP-1, shp-1 siRNA oligonucleotide was used. As shown in Figure 5d , transfection of rat VSMCs with shp-1 siRNA significantly reduced andrographolide-induced PP2A-C Tyr-307 dephosphorylation. shp-1 siRNA also restored andrographolidedecreased cell viability in rat VSMCs (Figure 5e ). Furthermore, siRNA experiments revealed that shp-1 siRNA suppressed the basal level of SHP-1 (Figure 5f ).
We also examined whether andrographolide activates SHP-1 in rat VSMCs. A member of a family of non-receptor protein tyrosine phosphatases (PTPs), SHP-1 contains 2 SH2 domains, and is activated by the phosphorylation of Tyr-564 4 . As shown in Figure 6a , andrographolide increased the phosphorylation of Tyr-564 in SHP-1. Andrographolide also significantly increased the phosphatase activity of SHP-1 (Figure 6b ). Consistent with the inhibitory effects of SSG, a reduction in SHP-1 enzyme activity was observed in rat VSMCs exposed to andrographolide in the presence of SSG (Figure 6b ). Moreover, the andrographolide-induced PP2A activation was significantly suppressed by SSG (Figure 6c ). These results suggest that SHP-1 may mediate andrographolide-induced dephosphorylation of PP2A-C Tyr-307 in rat VSMCs, which leads to the activation of the p38MAPK-p53-Bax cascade and subsequent apoptosis.
Discussion
Andrographolide, the principal bioactive compound in extracts of the leaves of A. paniculata, is a novel NF-kB inhibitor 8, 9, 15 . Our previously study showed that the PP2A-mediated dephosphorylation of NF-kB contributes to the protective anti-inflammatory properties of andrographolide in rat VSMCs. We also showed that andrographolide inhibited the formation of the neointima in a rat carotid balloon angioplasty model 16 . Our current findings demonstrate that andrographolide activates the SHP-1-PP2A-p38MAPK-p53 cascade, which induces Bax expression, mitochondria dysfunction, casepase-3 activation, and subsequent apoptosis in VSMCs.
We established previously that ceramide activation of the CAPP family member PP2A may be involved in andrographolide-induced p65 dephosphorylation in VSMCs 16 . In addition, PP2A activity is also regulated by phosphorylation 21, 24 . Phosphorylation of Tyr-307 in PP2A-C by Src family tyrosine kinases is required to maintain the inactivation of PP2A 24 . The signaling pathways that are required for andrographolide-induced activation of PP2A in VSMCs are not known. In our present study, we demonstrated that SSG, a specific inhibitor of SHP-1, inhibited both the andrographolide-induced dephosphorylation of Tyr-307 in PP2A-C and the activation of PP2A. Andrographolide also decreased cell viability in VSMCs through a SHP-1-dependent mechanism. These findings suggest that SHP-1 may play a pivotal role in the dephosphorylation of PP2A-C, the activation of PP2A, and subsequent signaling events in VSMCs exposed to andrographolide.
Although closely related in structure, the roles of SHP-1 and SHP-2 in cells are distinct. The SHP-1 protein regulates signaling in a negative manner 39 by suppressing the phosphorylation of proteins, whereas SHP-2 leads to cellular activation 40 . Despite their structural similarity, differences in their structures are likely related to their effects on phosphatase activity. However, the underlying mechanisms through which SHP-1 and SHP-2 regulate phosphatases remains unclear. Since SHP-1 is reported to be associated with the downregulation of Src 41, 42 , future studies of its role in the dephosphorylation of PP2A-C through Src inactivation are warranted.
The activation of PP2A has been shown to induce apoptosis by stimulating downstream signaling events, including the activation of p38MAPK 19 . Whether the p38MAPK signaling pathway contributes to andrographolide-induced apoptosis in VSMCs has not been demonstrated previously. Our current results show that p38MAPK was activated by andrographolide, and that its activation was causally related to apoptosis in VSMCs treated with andrographolide. In addition, we found that the andrographolide-induced activation of p38MAPK and subsequent apoptosis in VSMCs were mediated by PP2A. These findings are consistent with the observation that SB203580 and pp2a siRNA inhibit both the activation of p38 MAPK and the induction of apoptosis in VSMCs treated with andrographolide. In addition to p38MAPK signaling, we recently demonstrated that ceramide-p47phox-ROS signaling cascade contributes to andrographolide-induced VSMC apoptosis 43 . Bao et al. 44 also indicated that andrographolide causes apoptosis via inactivation Akt signaling. The link between these apoptotic pathways in VSMCs exposed to andrographolide remains to be established. These observations explain, at least in part, why blocking the p38MAPK signaling could not completely abolish andrographolide-induced VSMC apoptosis.
Increased oxidative stress may also contribute to andrographolide-induced apoptosis in VSMCs. It has been shown that mediators of oxidative stress, such as H 2 O 2 , may activate PP2A-like protein phosphatases, resulting in apoptosis 45 . We recently found that andrographolide increased the level of H 2 O 2 in VSMCs 43 . These observations suggest that andrographolide-induced oxidative stress may be critical in activating PP2A-p38MAPK-mediated apoptotic signaling in VSMCs.
The pro-apoptotic protein Bax causes apoptosis by disrupting mitochondrial integrity 46 . Yang et al. demonstrated that andrographolide induces the expression of Bax, activates caspases, and stimulates apoptosis in lymphoma cells 47 . Although the signaling events involved in andrographolide-induced Bax expression in VSMCs have not been delineated, p53 is likely to be involved. The expression of Bax is induced by p53 in response to selected stress signals 48 , and p53 activity is regulated by phosphorylation 16 . However, whether andrographolide alters the p53 phosphorylation has not been previously demonstrated. Our current results show that treatment of VSMCs with andrographolide caused p53 Ser-15 phosphorylation. The phosphorylation of p53 by p38MAPK contributes to multiple proposed apoptosis mechanisms 19, 49 . The expression and activation of proapoptotic function of Bax is also induced by PP2A 26 . These findings are consistent with our data which show that both the pp2a siRNA and SB203580 inhibited p53 phosphorylation, Bax expression, and apoptosis in VSMCs treated with andrographolide. Thus, andrographolide may activate the SHP-1-PP2A-p38MAPK cascade in VSMCs, causing subsequent p53 phosphorylation and apoptosis.
Andrographolide has also been shown to dephosphorylate the NF-kB p65 subunit, which results in the inactivation of NF-kB signaling 46 . The expression of a number of anti-apoptosis genes are regulated by NF-kB 50 . It is therefore possible that transcription factors other than p53, including NF-kB, may also contribute to andrographolide-induced apoptosis in VSMCs. The link between these transcription factors with regard to the apoptotic properties of andrographolide remains to be established.
In conclusion, the results of our present study demonstrate for the first time that andrographolide induces apoptosis in VSMCs. The apoptotic properties of andrographolide involve the activation of the SHP-1-PP2A-p38MAPK signaling cascade, p53 activation, and Bax expression.
Methods
Reagents. The Dulbecco modified Eagle medium (DMEM), optiMEM, trypsin (0.25%), L-glutamine, penicillin, streptomycin, fetal bovine serum (FBS), and the Dead Cell Apoptosis Kit with Annexin V Alexa Fluor 488 and PI were purchased from Gibco (Gaithersburg, MD, USA). The andrographolide ($98% purity), 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), dimethyl sulfoxide (DMSO), SB203580, ethylenediaminetetraacetic acid (EDTA), and sodium stibogluconate (SSG) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The p38MAPK inhibitor III was purchased from Millipore (Billerica, MA, USA). The Turbofect in vitro transfection reagent was purchased from Upstate Biotechnology (Lake Placid, NY, USA). The PG13-luc plasmid (Addgene, Cambridge, MA, USA) containing the p53 binding site was kindly provided by Dr. Bert Vogelstein 36 . The Renilla-luc and Dual-Glo luciferase assay systems were purchased from Promega (Madison, WI, USA). The 5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimidazolylcarbocyanine chloride (JC-1) was purchased from BioVision (Mountain View, CA, USA). The Hybond-P polyvinylidene difluoride (PVDF) membrane, enhanced chemiluminescence (ECL) detection reagent were purchased from Amersham (Buckinghamshire, UK). Andrographolide was dissolved in 0.1% dimethyl sulfoxide (DMSO), and stored at 4uC.
Antibodies. The anti-caspase-9 and anti-caspase-3 monoclonal antibodies (mAbs), anti-Bax polyclonal antibody (pAb), anti-phospho-p53 pAb, anti-p53 mAb, antiphospho-p38 MAPK mAb, anti-p38 MAPK mAb, and anti-phospho-SHP-1 mAb were purchased from Cell Signaling (Beverly, MA, USA). The anti-phospho-PP2A-C mAb, anti-demethylated-PP2A-C mAb, and anti-SHP-1 pAb were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). The anti-PP2A-C pAb was purchased from Genetex (San Antonio, TX, USA), and the anti-a-tubulin mAb was purchased from NeoMarkers (Fremont, CA, USA). The horseradish peroxidase (HRP)conjugated donkey anti-rabbit immunoglobulin G (IgG) and sheep anti-mouse IgG were purchased from Amersham.
Rat aortic SMC primary culture. Our animal protocols were approved by the Animal Care and Use Committee of Taipei Medical University. Male Wistar rats weighing 250 to 300 g were purchased from BioLASCO (Taipei, Taiwan), and were handled in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) . The VSMCs were harvested from male Wistar rats. Thoracic aortas from Wistar rats were removed, and stripped of endothelium and adventitia. The VSMCs were obtained by a modification of the combined collagenase and elastase digestion method 51 . The harvested VSMCs were grown in DMEM supplemented with 20 mM HEPES, 10% FBS, 1% penicillin/streptomycin, and 2 mM L-glutamine at 37uC in a humidified atmosphere of 5% CO 2 . The growth medium was changed every 2 to 3 days until cells were confluent. The growth medium was removed, and the monolayer was rinsed with phosphate-buffered saline (PBS). A trypsin-EDTA solution was added, and the monolayer was incubated at 37uC for 2 min. The culture dishes were observed under a phase-contrast microscope until the cells had detached. Cells were removed with 10 ml of DMEM, and centrifuged at 900 3 g for 7 min before being resuspended in DMEM. The cells from passages 4 to 8 were used in all of our experiments. Primary cultured rat aortic VSMCs showed the typical ''hills and valleys'' growth pattern, and the expression of a-smooth muscle actin was confirmed (data not shown).
Cell viability assay. The VSMCs (2 3 10 4 cells/well) were seeded in 24-well plates, and cultured in DMEM containing 10% FBS for 24 h. The VSMCs were pretreated with 20 or 50 mM andrographolide or an identical volume of solvent control (0.1% DMSO) for 24 or 48 h. Cell morphology was evaluated by phase contrast microscopy without preliminary fixation. The micrographs were recorded using a Nikon phasecontrast microscope (Tokyo, Japan). Cell viability was quantified using a colorimetric assay that measured the mitochondrial activity of the viable cells based on the reduction of MTT as previously described 52 . The cell number index was calculated as the ratio of the absorbance of treated cells to that of the control cells (treated/control) multiplied by 100%.
Apoptosis assays in rat VSMCs. The apoptosis assay was performed using annexin V/propidium iodide according to a method described previously 53 . The VSMCs (5 3 10 5 cells/dish) were incubated with 20 or 50 mM andrographolide or a solvent control. After 48 h, the cells were diluted to 1 3 10 6 cells/ml in annexin binding buffer, and incubated for 15 min with the Alexa Fluor 647 annexin V conjugate. The necrotic cells were identified with propidium iodide staining, and the cells were analyzed on a Coulter Epics XL flow cytometry (Beckman Coulter, Fullerton, CA, USA). The data were collected from 10000 cells per experimental group. All experiments were repeated at least 4 times to ensure reproducibility.
Mitochondrial membrane potential assay. The change in the mitochondrial membrane potential (ym) was determined using JC-1 as described previously 54 . The VSMCs (5 3 10 5 cells/dish) were incubated with 20 or 50 mM andrographolide or a solvent control. After 24 h, the VSMCs were combined with 2 mg/ml JC-1 in DMSO for 20 min. The final volume was brought to 1 ml for immediate analysis using a Coulter Epics XL flow cytometer. The selective entry of the lipophilic cationic fluorescence dye JC-1 from the cytosol into the mitochondria shifts the fluorescence of cells from red (JC-1 aggregates, FL3) to green (JC-1 monomers, FL1), and the loss of the selective uptake of JC-1 represents the Dym.
Immunoblotting. Immunoblotting was performed as described previously 51 . The VSMCs (5 3 10 5 cells/dish) were treated with 20 or 50 mM andrographolide or a solvent control for 20 min, and the proteins were extracted with lysis buffer. The lysates were centrifuged, the supernatant was collected, and 50 mg of soluble protein was analyzed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The separated proteins were electrophoretically transferred to a 0.45-mm PVDF membrane by semidry transfer (Bio-Rad, Hercules, CA, USA). Blots were blocked with 10 mM Tris-base, 100 mM NaCl, and 0.01% Tween 20 (TBST) containing 5% bovine serum albumin for 1 h, before being probed with the various primary antibodies. Membranes were incubated with HRP-anti-mouse IgG or anti-rabbit IgG (diluted 153000 in TBST) for 1 h. The immunoreactive bands were detected using the ECL system. The reactive bands were quantified using video densitometry and the Biolight for Microsoft Windows, version 2000.01, computer software (Bio-Profil, Vilber Lourmat, France).
Transfection and luciferase reporter assays. The cells were transfected with PG13luc and Renilla-luc plasmids using the Turbofect reagent. The treated or untreated cells were harvested, and the luciferase activity was determined using the Dual-Glo luciferase assay system kit. The luciferase activity was normalized based on the Renilla luciferase activity. The level of luciferase activity was quantified as the ratio of the activity of cells treated with andrographolide to that of untreated control cells.
Suppression of pp2a or shp-1 expression. The suppression of gene was examined as described previously 19 . For pp2a suppression, predesigned siRNAs targeting the rat pp2a gene were purchased from Ambion (Austin, TX, USA). The sequence of the siRNA oligonucleotide that targeted the coding region of the rat PP2A catalytic subunit (PP2A-C) mRNA was 59-CCAUACUCCGAGGGAAUCATT-39. For shp-1 suppression, predesigned siRNAs targeting the rat shp-1 gene were purchased from Sigma-Aldrich (St. Louis, MO, USA). The sequence of the siRNA oligonucleotide that targeted the coding region of the rat SHP-1 mRNA was 59-CAGUUCAUCGAAACAACCATT-39. The negative control siRNA contained a 19bp scrambled sequence with 39dT overhangs, and was also purchased from Ambion (Austin, TX, USA).
PP2A and SHP-1 phosphatase assay. We examined PP2A and SHP-1 phosphorylation using the Immunoprecipitation Phosphatase Assay kit (Millipore, Billerica, MA, USA), which quantifies the phosphorylation of a phosphopeptide substrate. For the PP2A phosphatase assay, 100 mg of cellular proteins was immunoprecipitated with a mouse anti-PP2A-C antibody (1 mg/ml; Millipore). The immunoprecipitated proteins were incubated with 750 mM phosphopeptide (amino acid sequence KRpTIRR) in protein phosphatase assay buffer for 10 min at 30uC to initiate the dephosphorylation of the phosphopeptide substrate. For the SHP-1 phosphatase assay, 100 mg of cellular proteins was immunoprecipitated with a rabbit anti-SHP-1 antibody (0.2 mg/ml; Santa Cruz Biotechnology). The immunoprecipitated proteins were incubated with 300 mM phosphopeptide (amino acid sequence RRLIEDAEpYAARG) in protein phosphatase assay buffer for 10 min at 30uC. The reactions were terminated by the addition of 100 ml of malachite green solution, and the absorbance at 650 nm was measured using a microplate reader.
Statistical analysis. The data are expressed as the mean 6 standard error of the results, and are accompanied by the number of observations. The data were assessed using an analysis of variance. If a significant difference occurred among the group means, each group was compared with the other groups using the Newman-Keuls method. A P , 0.05 was considered to indicate a statistically significant difference.
